IFAPP – WEBINAR: THE ENVOLVING REGULARORY/HTA INTERFACE UNDER THE NEW EUROPEAN HTA REGULATION
Date: 17th October 2024
Time: 11.00 – 12.00 AM CEST (see times in other locations below)
ABOUT THIS WEBINAR
In terms of summary, here a refined pitch for the announcement: “In an evolving ecosystem of decision making, close interaction between regulators and health technology assessment bodies is paramount to enable patient access to important new medicines and hence for the benefit of public health. This aims to generate evidence relevant for regulators, HTA bodies and other stakeholders thereby re-shaping and focusing medicine development programmes.
Furthermore, acknowledging the dependencies and remits, collaboration can also facilitate sequential decision-making by sharing information in the context of the respective assessments.
The webinar will focus on the newly evolving ecosystem in Europe, which provides unique opportunities for cooperation between the European Medicines Agency and the HTA Coordination group.”
AGENDA
Welcome: VARVARA BAROUTSOU, IFAPP President
Introduction – 5 mins (BIRKA LEHMANN)
The new HTA Regulation in Europe – 20 mins (ANNE WILLEMSEN. Dutch Zorginstituut – ZIN, EUnetHTA)
Evolving collaboration at the HTA/regulatory interface – 20 mins (MICHAEL BERNTGEN. PhD, MDRA, Head of Scientific Evidence Generation Department Human Medicines Division European Medicines Agency)
Q&A – 15 mins
Register in advance for this webinar
After registering, you will receive a confirmation email containing information about joining the webinar.
TIME SCHEDULE
04:00 – 05:00 AM EST
09:00 – 10:00 AM GMT
11:00 – 12:00 AM CEST
06:00 – 07:00 PM JST